Emerging roles of SUMO modification in arthritis.

Emerging roles of SUMO modification in arthritis.
复制标题

DOI:
10.1016/j.gene.2010.07.003
复制
发表时间:
2010-10-15
期刊:
影响因子:
3.5
通讯作者:
Im HJ
Im HJ
中科院分区:
生物学3区
文献类型:
--
作者:
Yan D;Davis FJ;Sharrocks AD;Im HJ

文献摘要

参考文献

被引文献

相似文献

Dynamic modification involving small ubiquitin-like modifier (SUMO) has emerged as a new mechanism of protein regulation in mammalian biology. Sumoylation is an ATP-dependent, reversible post-translational modification which occurs under both basal and stressful cellular conditions. Sumoylation profoundly influences protein functions and pertinent biological processes. For example, sumoylation modulates multiple components in the NFκB pathway and exerts an anti-inflammatory effect. Likewise, sumoylation of peroxisome proliferator-activated receptor γ (PPARγ) augments its anti-inflammatory activity. Current evidence suggests a role of sumoylation for resistance to apoptosis in synovial fibroblasts. Dynamic SUMO regulation controls the biological outcomes initiated by various growth factors involved in cartilage homeostasis, including basic fibroblast growth factors (bFGF or FGF-2), transforming growth factor-β (TGF-β) and insulin-like growth factor-1 (IGF-1). The impact of these growth factors on cartilage are through sumoylation-dependent control of the transcription factors (e.g., Smad, Elk-1, HIF-1) that are key regulators of matrix components (e.g., aggrecan, collagen) or cartilage-degrading enzymes (e.g., MMPs, aggrecanases). Thus, SUMO modification appears to profoundly affect chondrocyte and synovial fibroblast biology, including cell survival, inflammatory responses, matrix metabolism and hypoxic responses. More recently, evidence suggests that, in addition to their nuclear roles, the SUMO pathways play crucial roles in mitochondrial activity, cellular senescence, and autophagy. With an increasing number of reports linking SUMO to human diseases like arthritis, it is probable that novel and equally important functions of the sumoylation pathway will be elucidated in the near future.
DOI: 10.1186/ar2564
发表时间: 2008-01-01
影响因子: 4.9
作者:
Burrage, Peter S.;Schmucker, Adam C.;Brinckerhoff, Constance E.
通讯作者: Brinckerhoff, Constance E.
DOI: 10.1038/sj.onc.1208448
发表时间: 2005-05-05
期刊: ONCOGENE
影响因子: 8
作者:
Besnault-Mascard, L;Leprince, C;Vazquez, A
通讯作者: Vazquez, A
DOI: 10.1016/j.molcel.2006.05.016
发表时间: 2006-06-23
期刊: MOLECULAR CELL
影响因子: 16
作者:
Bischof, Oliver;Schwamborn, Klaus;Dejean, Anne
通讯作者: Dejean, Anne
DOI: 10.1002/art.24444
发表时间: 2009-05
影响因子: --
作者:
Bohensky, Jolene;Terkhorn, Shawn P.;Freeman, Theresa A.;Adams, Christopher S.;Garcia, Joseph A.;Shapiro, Irving M.;Srinivas, Vickram
通讯作者: Srinivas, Vickram
DOI: 10.1016/j.joca.2004.09.001
发表时间: 2004-12-01
影响因子: 7
作者:
Blumenkrantz, G;Lindsey, CT;Majumdar, S
通讯作者: Majumdar, S